Rothstein M - Search Results

1

Effects of phosphate binder therapy on vascular stiffness in early-stage chronic kidney disease.

Seifert ME, de las Fuentes L, Rothstein M, Dietzen DJ, Bierhals AJ, Cheng SC, Ross W, Windus D, Dávila-Román VG, Hruska KA. Seifert ME, et al. Among authors: rothstein m. Am J Nephrol. 2013;38(2):158-67. doi: 10.1159/000353569. Epub 2013 Aug 7. Am J Nephrol. 2013. PMID: 23941761 Free PMC article. Clinical Trial.

2

Left ventricular mass progression despite stable blood pressure and kidney function in stage 3 chronic kidney disease.

Seifert ME, de las Fuentes L, Ginsberg C, Rothstein M, Dietzen DJ, Cheng SC, Ross W, Windus D, Dávila-Román VG, Hruska KA. Seifert ME, et al. Among authors: rothstein m. Am J Nephrol. 2014;39(5):392-9. doi: 10.1159/000362251. Epub 2014 May 6. Am J Nephrol. 2014. PMID: 24818573 Free PMC article.

3

Renal tubular acidosis.

Rothstein M, Obialo C, Hruska KA. Rothstein M, et al. Endocrinol Metab Clin North Am. 1990 Dec;19(4):869-87. Endocrinol Metab Clin North Am. 1990. PMID: 2081516 Review.

4

Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria.

Pacifici R, Rothstein M, Rifas L, Lau KH, Baylink DJ, Avioli LV, Hruska K. Pacifici R, et al. Among authors: rothstein m. J Clin Endocrinol Metab. 1990 Jul;71(1):138-45. doi: 10.1210/jcem-71-1-138. J Clin Endocrinol Metab. 1990. PMID: 2370292

5

The effects of intraperitoneal calcitriol on calcium and parathyroid hormone.

Delmez JA, Dougan CS, Gearing BK, Rothstein M, Windus DW, Rapp N, Slatopolsky E. Delmez JA, et al. Among authors: rothstein m. Kidney Int. 1987 Mar;31(3):795-9. doi: 10.1038/ki.1987.68. Kidney Int. 1987. PMID: 3573540 Free article. Clinical Trial.

6

Dialysis enrollment patterns in Guatemala: evidence of the chronic kidney disease of non-traditional causes epidemic in Mesoamerica.

Laux TS, Barnoya J, Guerrero DR, Rothstein M. Laux TS, et al. Among authors: rothstein m. BMC Nephrol. 2015 Apr 14;16:54. doi: 10.1186/s12882-015-0049-x. BMC Nephrol. 2015. PMID: 25881146 Free PMC article.

7

Effects of erythropoietin stimulating agent (ESA) automated adjustment protocols on hemoglobin levels and mortality in end stage renal disease patients.

Kolankiewicz LM, Weinberg DA, Rothstein M, Weinberg MS. Kolankiewicz LM, et al. Among authors: rothstein m. Med Health R I. 2012 Jun;95(6):172-5. Med Health R I. 2012. PMID: 22866503 No abstract available.

8

Intravenous erythropoietin (rHuEPO) administration increases plasma endothelin and blood pressure in hemodialysis patients.

Carlini R, Obialo CI, Rothstein M. Carlini R, et al. Among authors: rothstein m. Am J Hypertens. 1993 Feb;6(2):103-7. doi: 10.1093/ajh/6.2.103. Am J Hypertens. 1993. PMID: 8471228 Clinical Trial.

9

Recombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cells.

Carlini RG, Dusso AS, Obialo CI, Alvarez UM, Rothstein M. Carlini RG, et al. Among authors: rothstein m. Kidney Int. 1993 May;43(5):1010-4. doi: 10.1038/ki.1993.142. Kidney Int. 1993. PMID: 8510379 Free article.

10

Acquired cystic disease of the kidney: a management dilemma.

Chandhoke PS, Torrence RJ, Clayman RV, Rothstein M. Chandhoke PS, et al. Among authors: rothstein m. J Urol. 1992 Apr;147(4):969-74. doi: 10.1016/s0022-5347(17)37436-0. J Urol. 1992. PMID: 1552615 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

355 results

Search Page

Filters